January 8, 2015 — Research and Markets has announced the addition of the "MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts" report to their offering.
The authors estimate the global nuclear imaging market to have been worth $1.77 billion in 2012 and $1.83 billion in 2013 and that this market will be worth $2.2 billion in 2020, increasing at a Compound Annual Growth Rate (CAGR) of 3.3% during the period of 2014 to 2020.
The nuclear imaging market is a moderately growing market with a 2014-2020 CAGR of 3.3% globally. It is a mature sector of the diagnostic imaging market. Continued growth is expected along with continued technological developments and the emerging markets' acceptance of products.
In 2012, the United States dominated the global nuclear imaging market, accounting for 69% of sales globally. The market is dominated by three companies: the market leader is Philips Healthcare with around 35% of the market by revenue, followed closely by GE Healthcare with around 33% of the market and Siemens Healthcare at just under 30%.
The United States is the largest market for nuclear imaging, in terms of the number of systems sold and the number of procedures carried out. However, a period of a rapid increase in procedures in the United States, particularly PET and PET/CT, has led to measures to reduce the number of procedures that can be reimbursed, and thus reduce the demand for nuclear imaging systems. Prior to healthcare reform, the major threat to the U.S. nuclear imaging market was the limited supply of radiopharmaceuticals.
For more information: www.researchandmarkets.com/research/2ksxvc/medipoint
October 19, 2026 
